Skip to main content

Health apps Market Future Growth, Segmentation, Regional Analysis and Competitive Landscape

Global Health apps Market Overview
global Health apps Market size is predicted to exhibit a stupendous 47.1% CAGR from 2017 to 2023 (forecast period). It is driven by the preference of mobile healthcare solutions amid the high penetration rate of smartphones and smart devices. According to the National Center for Biotechnology Information (NCBI), 68% of patients in the U.S. use a mobile health (mHealth) application for gaining advice on health problems and booking appointments.
Rise in healthcare facilities and medical professionals jumping on board the digital application bandwagon can bode well for the market. Presence of advanced telecommunication networks and a plethora of platforms for professionals to offer their expertise to patients can bolster the global Health apps Market demand in the coming years. The use of mobile applications by healthcare consumers is a positive indicator of the potential of the market. Seed funding and rising interest by venture capital firms can boost the market demand. In 2019, Xealth, a U.S. company gained funding from Philips, Novartis, ResMed, and McKesson Ventures.
Lack of patient awareness and hazy policies concerning patient information can pose a challenge to the market growth.
Segmentation Analysis
The Health apps Market is segmented by type, device, application, and end-user.
By type, it is segmented into Windows, Android, iPhone, and others.
By device, it is segmented into multi-parameter tracker, cardiac monitoring device, diabetes management device, and others.
By application, it is segmented into lifestyle management, disease management, fitness, nutrition, and diet, medication adherence, and others.
By end-user, it is segmented into home care, specialty centers, hospitals, sand others.
Competitive Outlook
Following are some of the major players in the Health apps Market. Traditional players are developing healthcare applications to digitize their offerings and gain a larger consumer base.
AirStrip Technologies
Sanofi
LifeWatch AG
Cerner Corporation
iHealth Lab
BioTelemetry Inc.
Apple Inc.
And others
The global Health apps Market report by Market Research Future encompasses numerous drivers and restraints which can enlighten readers and facilitate in making right investment decisions. The ubiquitousness of smartphones and smart devices have ensured the development of mobile applications. Prescribed health apps are software applications designed to provide health services over mobile devices. They assist patients by managing their medical condition in real-time and gaining advice from medical professionals via the mobile phone.
About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Comments

Popular posts from this blog

Immunoassay Analyzers Market By Methods, Technologies, Clinical Review and Industry Outlook

  Immunoassay Analyzers Market  Research Report By Instruments (Immunofluorescence, Chemiluminescence, ELISA, Radioimmunoassay), Application (Infectious Diseases, Autoimmune Diseases, AIDS), End Users (Hospitals)- Global Forecast till 2023 Market Scenario Immunoassay analyzer is a device which measures the presence and concentration of proteins in analyte samples. These instruments are mostly used by pharmaceutical & biotechnological companies, laboratories, and research institutes. The global immunoassay analyzer market is driven by an increasing number of pharmaceutical and biotechnological companies, rising prevalence of different life-threatening diseases, and government’s initiatives for research & development activities. Furthermore, rapid development in diagnostic medical devices, increasing need for better drug treatment, and the increasing geriatric population had also fueled the market’s growth. On the other hand, high cost of instruments and poor reimburseme...

Laser Therapy Market Top Company Profiles, Latest Technology, Global Size, Industry Trends

  Laser Therapy Market  Research Report, By Type (Diode Lasers, Solid State Lasers, Gas Lasers, Dye Lasers, and others), By Application (Dermatology and Aesthetics, Surgery, Dental, Urology, Ophthalmology, and others) - Global Forecast from 2017 to 2023 Market Overview: Market Research Future (MRFR) anticipates strong CAGR of 9.2% in the global laser therapy market over the forecast period of 2017-2023. The expansion of the global laser therapy is the result of various market dynamics, out of which, the surging prevalence of diseases such as cataract and arthritis bears profound weightage. Laser therapy is the standard line of treatment in cases of cataract. Laser-based ophthalmology is highly preferred over other methods of treatment. YAG LASER, excimer LASER, femtosecond LASER, and others are the most commonly used lasers in ophthalmology. The widespread prevalence of cataract, as well as arthritis, promote the growth of the global laser therapy market. Expanding base of old...

Nonallergic Rhinitis Market Data, Technology Treatment and Diagnosis Management Overview

  Nonallergic Rhinitis Market  Share, Growth And Trends Analysis By Diagnosis (Physical Examination, Allergy Testing, And Imaging Test), By Treatment (Nasal Sprays, Nsaids), And By End User (Hospitals &, Clinics, Research Centers) - Global Forecast Till 2023 Market Highlights Nonallergic rhinitis, also known as vasomotor rhinitis is a medical condition that refers to a set of symptoms that resemble nasal allergies and hayfever (allergic rhinitis) occurring without a known cause. Some of the symptoms of non-allergic rhinitis include Postnasal drip, Runny nose, Sneezing, and Stuffy nose among others. Some patients with nonallergic rhinitis may even develop allergies and asthma eventually, hence treating the condition well in time becomes essential. Industry, Innovation & Related News November 08, 2018 – AstraZeneca Plc. (the UK), a multinational pharmaceutical and biopharmaceutical company announced the sale of its rights for asthma drug Alvesco (ciclesonide), nasal spra...